SMTL ID : 6x82.2 (1 other biounit)

Crystal Structure of TNFalpha with isoquinoline compound 4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

homo-trimer

Ligands

1 x UTM: 8-[4-(2-{5-[(4-methylpiperazin-1-yl)methyl]-2-(1H-pyrrolo[3,2-c]pyridin-3-yl)phenoxy}ethyl)phenyl]isoquinoline(Non-covalent)

UTM.1: 22 residues within 4Å: Chain A: L.58, Y.60, S.61, L.121, G.122, Y.152, I.156, A.157, L.158 Chain B: L.58, Y.60, S.61, Y.120, L.121, G.122, Y.152, I.156 Chain C: L.58, I.59, Y.120, G.122, G.123 16 PLIP interactions: 5 interactions with chain A, 8 interactions with chain B, 3 interactions with chain C Hydrophobic interactions: A:L.58, A:L.58, A:Y.60, A:L.158, B:L.58, B:Y.60, B:Y.60, B:Y.120, B:Y.120, B:Y.120, B:Y.120, B:I.156, C:Y.120 pi-Stacking: A:Y.60 Hydrogen bonds: C:Y.120, C:Y.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dietrich, J.D. et al., Development of Orally Efficacious Allosteric Inhibitors of TNF alpha via Fragment-Based Drug Design. J.Med.Chem. (2021)

Release Date

2021-01-13

Peptides

Tumor necrosis factor: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

Tumor necrosis factor

Related Entries With Identical Sequence